Control of neuroblastoma cell proliferation and differentiation by human bone marrow

Cancer

Volumn 77, Issue 12, 1996, Pages 2614-2621

  Hahn, Talia ^a   Or, Reuven ^b   Bruchelt, Gernot ^c   Malach, Lea ^a   Karov, Yocheved ^a   Lifshitz Mercer, Beatriz ^a   Evron, Rina ^a   Barak, Yigal ^a  

^a KAPLAN HOSPITAL   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

bone marrow; cytokines; growth factors; neuroblstoma

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON; TUMOR NECROSIS FACTOR;

ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; GROWTH STIMULATION; HUMAN; HUMAN TISSUE; NEUROBLASTOMA; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

BONE MARROW; CELL DIFFERENTIATION; CELL DIVISION; CLONE CELLS; CYTOKINES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERFERON TYPE II; NEUROBLASTOMA; TUMOR CELLS, CULTURED;

EID: 0029888281     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960615)77:12<2614::AID-CNCR27>3.0.CO;2-U     Document Type: Article

References (21)

1. De Bernardi B, Rogers D, Carli M, Madon E, De Laurentis T, Bagnulo S, et al. Localized neuroblastoma. Cancer 1987;60:1066-72.
2. Evans AE, D'Angio GJ, Propert K, Anderson J, Hann HWL. Prognostic factors in neuroblastoma. Cancer 1987;59:1853-9.
3. Philip T, Zucker JM, Bernard P, Lutz P, Bordigoni P, Plouvier E, et al. Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than one year of age at diagnosis: is cure possible in a small subgroup? J Clin Oncol 1991;9:1037-44.
4. Tanaka T. Ha-ras p21 in neuroblastoma: a new marker in prediction of patient outcome. In: Evans AE, Biedler JL, Brodeur GM, D'Angio GJ, Nakagawara A, editors. Advances in Neuroblastoma Research 4. New York: Wiley-Liss Inc., 1994:275-80.
5. Ikegaki N, Katsumata M, Tsujimoto Y. The expression and modulation of proteins associated with physiological cell death in neuroblastoma cells. In: Evans AE, Biedler JL, Brodeur GM, D'Angio GJ, Nakagawara A, editors. Advances in Neuroblastoma Research 4. New York: Wiley-Liss Inc., 1994:117-22.
6. Haas D. Complete pathologic maturation and regression of stage IV-S neuroblastoma without treatment. Cancer 1988;62:818-25.
7. Ponzoni M, Casalaro A, Lanciatti M, Montaldo PG, Cornaglia-Ferraris P. The combination of γ interferon and tumor necrosis factor causes a rapid and extensive differentiation of human neuroblastoma cells. Cancer Res1992;52:931-9.
8. Kushner BH, Cheung N-K. GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma. Blood 1989;73:1936-41.
9. Sonnenfeld KH, Ishii DN. Nerve growth factor effects and receptors in cultured human neuroblastoma cell lines. J Neurosci Res 1982;8:375-91.
10. Suardet I, Gross N, Gaide AC, Beck D, Eliason JF. Epidermal growth factor responsiveness of a new human neuroblastoma cell line. Int J Cancer 1989;44:661-8.
11. Gospodarowicz D, Neufeld G, Schweigerer L. Molecular and biological characterization of fibroblast growth factor, an angiogenic factor which also controls the proliferation and differentiation of mesoderm- and neuroectoderm-derived cells. Cell Differentiation 1986;19:1-17.
12. Mosman T. Rapid colorimetric assay for cellular growth and cytotoxicity. J Immunol Methods 1983;65:55-62.
13. Fidler IJ, Schroit AJ. Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self. Biochim Biophys Acta 1988;948:151-73.
14. Montovani A, Bottazzi B, Collota F, Sozziani S, Ruco L. The origin and function of tumor-associated macrophages. Immunol Today 1992;13:265-70.
15. Mannel DN, Orosz P, Hafner M, Falk W. Mechanisms involved in metastasis enhanced by inflammatory mediators. Circ Shock 1994;44:9-13.
16. Orosz P, Echtenacher B, Falk W, Ruschoff I, Weber D, Mannel DN. Enhancement of experimental metastasis by tumor necrosis factor. J Exp Med 1993;177:1391-8.
17. Lollini PL, Bosco MC, Cavallo F, DeGiovanni C, Giovarelli M, Landuzzi L, et al. Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene. Int J Cancer 1993;55:320-9.
18. Shaw G, Weber K. Differential expression of neurofilament triplet proteins in brain development. Nature 1982;298:277-9.
19. Ross RA, Spengler BA, Biedler JL. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst 1983;71:741-7.
20. Reynolds CP, Maples J. Modulation of cell surface antigens accompanies morphological differentiation of neuroblastoma cell lines. In: Evans AE, D'Angio GJ, Seeger RC, editors. Advances in Neuroblastoma Research. New York: Wiley-Liss Inc., 1985:13-37.
21. Spengler BA, Domenech C, Porubcin M, Biedler JL. Human neuroblastoma lines respond to diverse differentiation-inducing agents. In: Evans AE, Biedler JL, Brodeur GM, D'Angio GJ, Nakagawara A, editors. Advances in Neuroblastoma Research 4. New York: Wiley-Liss Inc., 1994:261-7.